iShares US Pharmaceuticals (IHE)
AMEX
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 0.72 | 1.402 | 4.016 | -9.98 | 29.401 | 10.055 | -8.942 | 20.006 |
Return on Equity (%) | 0.842 | 1.618 | 4.475 | -10.481 | 30.543 | 10.422 | -9.295 | 20.908 |
Return on Invested Capital (%) | 744.873 | 1651.244 | 1020.814 | 587.139 | 521.556 | 1010.578 | 1599.533 | 991.847 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 150.968 | 147.203 | 154.046 | 134.831 | 177.381 | 194.178 | 175.423 | 67.91 |
Earnings Per Share | 1.2 | 3.38 | 6.938 | -16.911 | 48.194 | 18.922 | -16.967 | 11.164 |
Cash Per Share | N/A | N/A | N/A | 0.089 | N/A | 0.003 | 0.1 | 0.071 |
Working Capital Per Share | 0.142 | 0.155 | 0.189 | 0.581 | 0.304 | 0.296 | 0.11 | 0.148 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | 2.475 | 6.745 | 8.781 | -14.52 | 50.457 | 21.985 | -13.198 | 11.902 |
Fin d'année 31 Mars 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 4,75M | 2,65M | 2,5M | 2,05M | 2M | 2,1M | 2,15M | 9,7M |
Fin d'année 31 Mars 2024 | ||||||||
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | N/A | |||||||
Return on Assets (%) | N/A | |||||||
Return on Equity (%) | N/A | |||||||
Return on Invested Capital (%) | N/A | |||||||
Operating Margin (%) | N/A | |||||||
Net Profit Margin (%) | N/A | |||||||
Sales Per Share | N/A | |||||||
Book Value Per Share | N/A | |||||||
Earnings Per Share | N/A | |||||||
Cash Per Share | N/A | |||||||
Working Capital Per Share | N/A | |||||||
Operating Profit Per Share | N/A | |||||||
EBIT Per Share | N/A | |||||||
EBITDA Per Share | N/A | |||||||
Free Cash Flow Per Share | N/A | |||||||
Current Ratio | N/A | |||||||
Quick Ratio | N/A | |||||||
Inventory Turnover (Days) | N/A |
Capitalisation boursière | 636,71M |
Ratio cours/bénéfice | 5,89 |
Ratio prix/ventes | 62,7 |
Ratio prix/liquidités | 929,24 |
Ratio prix/valeur comptable | 0,97 |
Rendement de dividende | 138,13% |
Actions en circulation | 9,7M |
Volume moyen (1 semaine) | 77,51k |
Volume moyen (1 mois) | 83,55k |
Variation sur 52 semaines | 2,82% |
Plus haut sur 52 semaines | 72,94 |
Plus bas sur 52 semaines | 62,2851 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales